Veradermics, Incorporated (MANE)
NYSE: MANE · Real-Time Price · USD
63.75
+1.83 (2.96%)
Mar 24, 2026, 2:51 PM EDT - Market open

Veradermics Stock Forecast

Stock Price Forecast

The 3 analysts that cover Veradermics stock have a consensus rating of "Strong Buy" and an average price target of $78.33, which forecasts a 22.87% increase in the stock price over the next year. The lowest target is $75 and the highest is $85.

Price Target: $78.33 (+22.87%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$75$78.33$75$85
Change+17.65%+22.87%+17.65%+33.33%

Analyst Ratings

The average analyst rating for Veradermics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMar '26
Strong Buy2
Buy2
Hold0
Sell0
Strong Sell0
Total4

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Initiates
n/a
BuyInitiatesn/an/aMar 2, 2026
Citigroup
Citigroup
Strong Buy
Initiates
$85
Strong BuyInitiates$85+33.33%Mar 2, 2026
Leerink Partners
Leerink Partners
Buy
Initiates
$75
BuyInitiates$75+17.65%Mar 2, 2026
Jefferies
Jefferies
Strong Buy
Initiates
$75
Strong BuyInitiates$75+17.65%Mar 2, 2026

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
14.13M
EPS This Year
n/a
from -37.05
EPS Next Year
n/a
Fiscal YearFY 2023FY 2024FY 2026FY 2027FY 2028
Period EndingDec 31, 2023Dec 31, 2024Dec 31, 2026Dec 31, 2027Dec 31, 2028
Revenue
---14.13M47.12M
Revenue Growth
----233.53%
EPS
-22.38-37.05---
EPS Growth
-----
Forward PE
-----
No. Analysts
--454
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202620272028
Highn/a43.6M
Avgn/a14.1M
Lown/an/a

Revenue Growth

Revenue Growth202620272028
High--
Avg--
Low--

EPS Forecast

EPS
High
Avg
Low

EPS Growth

EPS Growth
High
Avg
Low
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.